COVID 19 Antibodies for IgG, IgA, and IgM - KSL Chemiluminescence Assay

GTR Test IDHelpEach Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. When a laboratory updates a registered test, a new version number is assigned.: GTR000593853.1
Last updated: 2021-08-25
Annual Review past due read more
Test version history
- 593853.1, last updated: 2021-08-25

Clinical microbial testHelpIn the U.S., clinical tests must be performed under CLIA certification. When a lab uses the same methods for a test in both clinical and research settings, the test appears as two separate GTR records. for COVID-19
Offered by KSL Diagnostics

Indication

This is a clinical microbial test intended for HelpPurposes or indications for the test. Lab-provided.: Screening

An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction. [from NCI]

Conditions tested

This test is used for the detection of IgA, IgG, and IgM antibodies to SARS-CoV-2 S1 domain spike protein in patients following COVID-19 infection or in individuals who have been vaccinated.

Citations

Not provided

Reviews

Clinical resources

Practice guidelines

NICE, 2024
UK NICE Guideline NG191, COVID-19 rapid guideline: managing COVID-19, 2024

Consumer resources

MedlinePlus

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

COVID 19 Antibodies for IgG, IgA, and IgM - KSL Chemiluminescence Assay

Indication

Clinical summary

Conditions tested

Target population

Citations

Clinical validity

Clinical utility

Reviews

Clinical resources

Practice guidelines

Consumer resources